Smart drug GRWD5769 shrinks lung cancer tumours by nearly 30% in patient trial (theguardian.com)

• Pat Brogan's tumours shrunk by ~30% after GRWD5769 treatment.
• Drug prevents cancer cells from hiding from immune system, enhancing immunotherapy.
• Findings presented at ASCO conference; patient resumes normal life.

"A 68-year-old lung cancer patient, Pat Brogan, saw tumours shrink by almost 30% after receiving the smart drug GRWD5769, which prevents cancer cells from hiding from the immune system. The results were presented at the ASCO conference in Chicago. Brogan, diagnosed with stage four lung cancer in 2021, is now able to walk his daughter down the aisle and plan holidays."